Related references
Note: Only part of the references are listed.Immune Response Regulation by Antigen Receptors' Clone-Specific Nonself Parts
Hilmar Lemke
FRONTIERS IN IMMUNOLOGY (2018)
Overlooked benefits of using polyclonal antibodies
Carl A. Ascoli et al.
BIOTECHNIQUES (2018)
Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen
Ahsan Naveed et al.
MSPHERE (2018)
Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial
Nikolai Siebert et al.
CANCERS (2018)
Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects
Laura F. Hutchins et al.
ONCOTARGET (2017)
Antigen Receptor-Intrinsic Non-Self: The Key to Understanding Regulatory Lymphocyte-Mediated Idiotypic Control of Adaptive Immune Responses
Hilmar Lemke
CRITICAL REVIEWS IN IMMUNOLOGY (2016)
Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2
Nikolai Siebert et al.
MABS (2016)
Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture
Nicole Baumgarth et al.
B-1 CELL DEVELOPMENT AND FUNCTION (2015)
Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis
Anna-Karin E. Palm et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Autoreactivity and the positive selection of B cells
Rudolf Uebelhart et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Moving a carbohydrate mimetic peptide into the clinic Clinical response of a breast cancer patient after mimotope-based immunotherapy
Issam Makhoul et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
Sailyn Alfonso et al.
CLINICAL CANCER RESEARCH (2014)
Validated detection of human anti-chimeric immune responses in serum of neuroblastoma patients treated with ch14.18/CHO
Nikolai Siebert et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes
Andrea Cerutti et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
Nai-Kong V. Cheung et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The promise of the anti-idiotype concept
Thomas Kieber-Emmons et al.
FRONTIERS IN ONCOLOGY (2012)
Anti- gangliosideanti- idiotypicvaccination: morethanmolecularmimicry
Ana M. H. Vazquez et al.
FRONTIERS IN ONCOLOGY (2012)
Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements
Maha Zohra Ladjemi
FRONTIERS IN ONCOLOGY (2012)
Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in lupus-prone mice
Zhenhai Zhou et al.
BMC IMMUNOLOGY (2011)
Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology
Leah Hennings et al.
Cancers (2011)
Novel Anti-idiotype Antibody Therapy for Lipooligosaccharide-Induced Experimental Autoimmune Neuritis: Use Relevant to Guillain-Barre Syndrome
S. Usuki et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
Ana Maria Hernandez et al.
JOURNAL OF IMMUNOLOGY (2008)
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice
Assefa Wondimu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group b study 89903
Mitchell C. Posner et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer -: Report of a phase I trial
Elia Neninger et al.
CANCER BIOLOGY & THERAPY (2007)
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer
G Chong et al.
ANNALS OF ONCOLOGY (2006)
Evidence of marginal-zone B cell-positive selection in spleen
LJ Wen et al.
IMMUNITY (2005)
Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma
JL Murray et al.
CANCER RESEARCH (2004)
Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides
A Díaz et al.
CLINICAL IMMUNOLOGY (2003)
A monoclonal antibody against NeuGc-containing gangliosides contains a regulatory idiotope involved in the interaction with B and T cells
A Perez et al.
MOLECULAR IMMUNOLOGY (2002)
Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2
KA Foon et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
